All Stories

  1. Neurodiversity and humanism in autism: An LMIC health care setting perspective
  2. Sustainable Development Goals summit 2023 and the global pledge on disability-focused early childhood development
  3. UNICEF and global leadership for disability inclusion in early childhood
  4. Global leadership is needed to optimize early childhood development for children with disabilities
  5. The Nurturing Care Framework and Children With Developmental Disabilities in LMICs
  6. Mapping Local Variations and the Determinants of Childhood Stunting in Nigeria
  7. Disabilities in Early Childhood: A Global Health Perspective
  8. Global investments to optimise the health and wellbeing of children with disabilities: a call to action
  9. Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018
  10. The overlapping burden of the three leading causes of disability and death in sub-Saharan African children
  11. Revisiting the Role of Pediatricians for Optimal Early Childhood Development in LMICs
  12. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  13. Solid Fuel Use and Health in Developing Countries
  14. BMJ Paediatrics Openand the Global South: an open call towards editorial diversity and inclusion
  15. Global and regional prevalence of disabilities among children and adolescents: Analysis of findings from global health databases
  16. Prioritising rehabilitation in early childhood for inclusive education: a call to action
  17. Cerebral palsy and developmental intellectual disability in children younger than 5 years: Findings from the GBD-WHO Rehabilitation Database 2019
  18. Validation of the Decision model of the Burden of Hearing loss Across the Lifespan (DeciBHAL) in Chile, India, and Nigeria
  19. Child health, inclusive education and development
  20. The Role of Parenting Interventions in Optimizing School Readiness for Children With Disabilities in Low and Middle Income Settings
  21. Clarifying Best Practices for Early Childhood Development
  22. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study
  23. Accelerating progress on early childhood development for children under 5 years with disabilities by 2030
  24. Disability in children: a global problem needing a well-coordinated global action
  25. Global investment to reduce the burden of hearing loss
  26. Heliotherapy for Neonatal Hyperbilirubinemia: Some Clarifications and Update
  27. Revisiting the prevalence and population of children with neurological impairments in sub‐Saharan Africa
  28. Mapping Anemia in Women: Global Trends and Inequality
  29. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019
  30. Dismantling Structural Discrimination in Global Health
  31. Child Mortality Trends and Targets: GBD 2019 Findings
  32. Systemic racism in global health: a personal reflection
  33. Infant and Young Child Feeding Practices among Adolescent Mothers and Associated Factors in India
  34. Setting the record straight on measuring SDG 4.2.1 – Authors' reply
  35. Transforming global health through equity-driven funding
  36. Mapping inequalities in exclusive breastfeeding in low- and middle-income countries, 2000–2018
  37. Subnational mapping of HIV incidence and mortality among individuals aged 15–49 years in sub-Saharan Africa, 2000–18: a modelling study
  38. Beyond pledges: academic journals in high-income countries can do more to decolonise global health
  39. The conundrum of a global tool for early childhood development to monitor SDG indicator 4.2.1
  40. Hearing loss prevalence and years lived with disability
  41. Accountability framework to decolonise global health
  42. Mapping routine measles vaccination in low- and middle-income countries
  43. Five insights from the Global Burden of Disease Study 2019
  44. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019
  45. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  46. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  47. Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17
  48. The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis
  49. Promoting Inclusive Early Childhood Development under the SDG Era
  50. Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17
  51. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  52. Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
  53. Global Burden of Childhood Epilepsy, Intellectual Disability, and Sensory Impairments
  54. Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
  55. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3
  56. GBD 2016. Occupational Carcinogens Collaborators
  57. Global and regional burden of chronic respiratory disease in 2016 arising from non-infectious airborne occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016
  58. Global and regional burden of disease and injury in 2016 arising from occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016
  59. Mapping child growth failure across low- and middle-income countries
  60. Mapping disparities in education across low- and middle-income countries
  61. Premature mortality in children with developmental disabilities
  62. Mapping 123 million neonatal, infant and child deaths between 2000 and 2017
  63. Hearing loss: rising prevalence and impact
  64. Bolajoko Olusanya: personal challenges, public health
  65. Hearing loss grades and the International classification of functioning, disability and health
  66. Correction to: Regional prevalence and determinants of exclusive breastfeeding in India
  67. Diseases, Injuries, and Risk Factors in Child and Adolescent Health, 1990 to 2017
  68. Regional prevalence and determinants of exclusive breastfeeding in India
  69. Poor data produce poor models: children with developmental disabilities deserve better – Authors' reply
  70. Diarrhoea deaths and disability-adjusted life years attributable to suboptimal breastfeeding practices in Nigeria: findings from the global burden of disease study 2016
  71. Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  72. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
  73. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease ...
  74. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  75. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  76. Measuring progress of the health-related Sustainable Development Goals for 195 countries
  77. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  78. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  79. Department of Error
  80. Nurturing care for children with developmental disabilities: a moral imperative for sub-Saharan Africa
  81. Developmental disabilities among children younger than 5 years in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  82. Tuberculosis disease burden and attributable risk factors in Nigeria, 1990–2016
  83. Alcohol use and attributable disease burden in 195
  84. Neonatal hyperbilirubinaemia: a global perspective
  85. TV listening and hearing aids
  86. Measuring performance_Healthcare Access_Quality Index for 195 countries and territories
  87. RE: Global Initiatives for Early Childhood Development Should Be Disability Inclusive
  88. The Contribution of Neonatal Jaundice to Global Child Mortality: Findings From the GBD 2016 Study
  89. Timely sensory stimulation and early childhood development
  90. Burden of severe neonatal jaundice: a systematic review and meta-analysis
  91. Department of Error
  92. Severe neonatal hyperbilirubinaemia is frequently associated with long hospitalisation for emergency care in Nigeria
  93. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016
  94. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
  95. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  96. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  97. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  98. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016
  99. Department of Error
  100. Obligations under global health partnerships in LMICs should be contractual
  101. Maternal detection of neonatal jaundice during birth hospitalization using a novel two-color icterometer
  102. Adolescent health in the Eastern Mediterranean Region: findings from the global burden of disease 2015 study
  103. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015
  104. Child and Adolescent Health From 1990 to 2015
  105. A neurologic dysfunction scoring protocol for jaundiced neonates requiring exchange transfusion
  106. Transcutaneous bilirubin nomograms in African neonates
  107. Department of Error
  108. Global, Regional, and National Levels of Maternal Mortality, 1990–2015
  109. Use of Transcutaneous Bilirubin to Determine the Need for Phototherapy in Resource-Limited Settings
  110. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  111. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  112. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  113. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
  114. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
  115. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  116. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015
  117. Correction to Lancet HIV 2016; 3: e361–87
  118. Differences Between Transcutaneous and Serum Bilirubin Measurements in Black African Neonates
  119. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015
  120. The authors reply
  121. Training pediatric emergency medicine specialists in India
  122. Irradiance Decay in Fluorescent and Light-emitting Diode-based Phototherapy Devices: A Pilot Study
  123. Heliotherapy for Neonatal Hyperbilirubinemia in Southwest, Nigeria: A Baseline Pre-Intervention Study
  124. Aging and Hearing Health: The Life-course Approach
  125. A decision-making tool for exchange transfusions in infants with severe hyperbilirubinemia in resource-limited settings
  126. Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013
  127. Predictors of Repeat Exchange Transfusion for Severe Neonatal Hyperbilirubinemia*
  128. The burden and management of neonatal jaundice in Nigeria: A scoping review of the literature
  129. Facility-based constraints to exchange transfusions for neonatal hyperbilirubinemia in resource-limited settings
  130. 10.1016/S0140-6736(15)60692-4
  131. Revisiting the Criteria for Exchange Transfusion for Severe Neonatal Hyperbilirubinemia in Resource-Limited Settings
  132. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition
  133. Infants at risk of significant hyperbilirubinemia in poorly-resourced countries: evidence from a scoping review
  134. A Randomized Trial of Phototherapy with Filtered Sunlight in African Neonates
  135. Structure, function and five basic needs of the global health research system
  136. Screening for neonatal deafness in resource-poor countries: challenges and solutions
  137. Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings
  138. A modified Bilirubin-induced neurologic dysfunction (BIND-M) algorithm is useful in evaluating severity of jaundice in a resource-limited setting
  139. Prevalence of Congenital Cytomegalovirus Infection in Nigeria
  140. Risk Factors for Severe Neonatal Hyperbilirubinemia in Low and Middle-Income Countries: A Systematic Review and Meta-Analysis
  141. Societal impact of bilirubin-induced hearing impairment in resource-limited nations
  142. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  143. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  144. Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  145. Addressing the burden of neonatal hyperbilirubinaemia in countries with significant glucose-6-phosphate dehydrogenase deficiency
  146. Why is kernicterus still a major cause of death and disability in low-income and middle-income countries?
  147. Maternal satisfaction with a novel filtered-sunlight phototherapy for newborn jaundice in Southwest Nigeria
  148. Newborn health research priorities beyond 2015
  149. Safety and Efficacy of Filtered Sunlight in Treatment of Jaundice in African Neonates
  150. Pattern and predictors of maternal care-seeking practices for severe neonatal jaundice in Nigeria: a multi-centre survey
  151. Letter to the Editor regarding ‘Hearing impairment, severe hyperbilirubinemia and heliotherapy’
  152. The global burden of disabling hearing impairment: a call to action
  153. Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels
  154. Letter to the Editor regarding ‘Investigating the burden of hyperbilirubinemia in resource-constrained settings’
  155. Evaluation of Window-Tinting Films for Sunlight Phototherapy
  156. Phototherapy Device Effectiveness in Nigeria: Irradiance Assessment and Potential for Improvement
  157. Pattern and Characteristics of Growth Faltering in Early Infancy in an Urban Sub-Saharan African Setting
  158. Treatment of neonatal jaundice with filtered sunlight in Nigerian neonates: study protocol of a non-inferiority, randomized controlled trial
  159. Risk of sensorineural hearing loss in infants with abnormal head size
  160. Full-term newborns with normal birthweight requiring special care in a resource-constrained setting
  161. Addressing the needs of adolescent mothers and their offspring in Nigeria: a community-based study
  162. Undernutrition and Hearing Impairment
  163. Paediatricians’ perspectives on global health priorities for newborn care in a developing country: a national survey from Nigeria
  164. Full-term newborns with congenital microcephaly and macrocephaly in Southwest Nigeria
  165. Neonatal hearing screening and intervention in resource-limited settings: an overview
  166. Perinatal Outcomes of Multiple Births in Southwest Nigeria
  167. Pattern of head growth and nutritional status of microcephalic infants at early postnatal assessment in a low-income country
  168. Maternal antecedents of infants with abnormal head sizes in southwest Nigeria: A community-based study
  169. Global and regional hearing impairment prevalence: an analysis of 42 studies in 29 countries
  170. Permanent Hearing Loss among Professional Spice Grinders in an Urban Community in Southwest Nigeria
  171. CHILD SURVIVAL AND CHILD DEVELOPMENT IN DEVELOPING COUNTRIES
  172. Perinatal correlates of delayed childbearing in a developing country
  173. Predictors of growth velocity in early infancy in a resource-poor setting
  174. Priorities for Early Childhood Development in Low-Income Countries
  175. Is home birth a marker for severe malnutrition in early infancy in urban communities of low-income countries?
  176. Highlights of the new WHO Report on Newborn and Infant Hearing Screening and implications for developing countries
  177. Maternal and neonatal profile of late-preterm survivors in a poorly resourced country
  178. Infants Delivered in Maternity Homes Run by Traditional Birth Attendants in Urban Nigeria: A Community-Based Study
  179. Making targeted screening for infant hearing loss an effective option in less developed countries
  180. Perinatal Outcomes Associated with Maternal Hypertensive Disorders of Pregnancy in a Developing Country
  181. Predictors of early-onset permanent hearing loss in malnourished infants in Sub-Saharan Africa
  182. Is discordance in TEOAE and AABR outcomes predictable in newborns?
  183. Surrogate measurements for identifying newborns with low birth weight in a community with predominant non-hospital births
  184. Prevalence, pattern and risk factors for undernutrition in early infancy using the WHO Multicentre Growth Reference: a community-based study
  185. Preference for private hospital-based maternity services in inner-city Lagos, Nigeria: An observational study
  186. Intrauterine growth restriction in a low-income country: Risk factors, adverse perinatal outcomes and correlation with current WHO Multicenter Growth Reference
  187. Ambient noise levels and infant hearing screening programs in developing countries: An observational report
  188. Reducing the burden of severe neonatal jaundice in G6PD-deficient populations in low-income countries: are we doing enough?
  189. Pattern and determinants of BCG immunisation delays in a sub-Saharan African community
  190. Telehealth in audiology: The need and potential to reach underserved communities
  191. Perinatal profile of very low birthweight infants under a universal newborn hearing screening programme in a developing country: A case-control study
  192. Hearing health-care delivery in sub-Saharan Africa – a role for tele-audiology
  193. NON-UPTAKE OF FACILITY-BASED MATERNITY SERVICES IN AN INNER-CITY COMMUNITY IN LAGOS, NIGERIA: AN OBSERVATIONAL STUDY
  194. Is undernutrition a risk factor for sensorineural hearing loss in early infancy?
  195. Predictors of term stillbirths in an inner-city maternity hospital in Lagos, Nigeria
  196. Predictors of Preterm Births and Low Birthweight in an Inner-City Hospital in Sub-Saharan Africa
  197. Maternal and neonatal factors associated with mode of delivery under a universal newborn hearing screening programme in Lagos, Nigeria
  198. Place of birth and characteristics of infants with congenital and early-onset hearing loss in a developing country
  199. Adverse neonatal outcomes associated with trial of labor after previous cesarean delivery in an inner-city hospital in Lagos, Nigeria
  200. Infants with HIV-infected mothers in a universal newborn hearing screening programme in Lagos, Nigeria
  201. Optimising the use of routine immunisation clinics for early childhood development in sub-Saharan Africa
  202. Sensorineural hearing loss in infants with neonatal jaundice in Lagos: a community-based study
  203. Follow-up default in a hospital-based universal newborn hearing screening programme in a low-income country
  204. Newborns at risk of sensorineural hearing loss in low-income countries
  205. Community-based infant hearing screening in a developing country: parental uptake of follow-up services
  206. Universal infant hearing screening programme in a community with predominant non-hospital births: a three-year experience
  207. Costs and performance of early hearing detection programmes in Lagos, Nigeria
  208. Infants with severe neonatal jaundice in Lagos, Nigeria: incidence, correlates and hearing screening outcomes
  209. Predictors of term stillbirths in an inner-city maternity hospital in Lagos, Nigeria*
  210. Are risk factors for stillbirths in low-income countries associated with sensorineural hearing loss in survivors?
  211. Comment on Baltussen and SmithCost-effectiveness of selected interventions for hearing impairment in Africa and Asia: A mathematical modelling approach
  212. Community-based infant hearing screening for early detection of permanent hearing loss in Lagos, Nigeria: a cross-sectional study
  213. Non-hospital delivery and permanent congenital and early-onset hearing loss in a developing country
  214. The Need for Standardization of Methods for Worldwide Infant Hearing Screening: A Systematic Review
  215. Hospital-based universal newborn hearing screening for early detection of permanent congenital hearing loss in Lagos, Nigeria
  216. Pitfalls in the diagnosis and management of transient synovitis of the hip: a retrospective case-note analysis
  217. Priorities for early hearing detection and intervention in sub-Saharan Africa
  218. Factors associated with auditory neuropathy/dys-synchrony in a developing country
  219. <p>Early hearing detection at immunization clinics in developing countries</p>
  220. Correction: Addressing the Global Neglect of Childhood Hearing Impairment in Developing Countries
  221. Addressing the Global Neglect of Childhood Hearing Impairment in Developing Countries
  222. Global burden of childhood hearing impairment and disease control priorities for developing countries
  223. “The Right Stuff”: The Global Burden of Disease
  224. Progress towards early detection services for infants with hearing loss in developing countries
  225. Promoting effective interventions for neglected health conditions in developing countries
  226. Health priorities for developing countries: importance of non-fatal but disabling conditions
  227. Early detection of infant hearing loss: Current experiences of health professionals in a developing country
  228. Ethical issues in screening for hearing impairment in newborns in developing countries
  229. Adverse perinatal conditions in hearing-impaired children in a developing country
  230. Early hearing detection at immunization clinics in developing countries
  231. Reducing the Burden of Communication Disorders in the Developing World
  232. Revisiting the ten questions questionnaire for developing countries
  233. Stillbirths in sub-Saharan Africa
  234. Globalization of Infant Hearing Screening: The Next Challenge before JCIH?
  235. Communication disorders in Nigerian children
  236. Maternal views on infant hearing loss in a developing country
  237. Letter to the Editors: The burden of neonatal jaundice and sepsis in developing countries
  238. Disabilities, physicians and the millennium development goals
  239. Physician education on infant hearing loss in a developing country
  240. <p>Predictors of hearing loss in school entrants in a developing country</p>
  241. <p>Childhood deafness poses problems in developing countries</p>
  242. Screening for early childhood hearing loss in Nigeria
  243. Can the world's infants with hearing loss wait?
  244. State of the world's children: life beyond survival
  245. Childhood deafness poses problems in developing countries
  246. Infant hearing screening: route to informed choice
  247. Classification of childhood hearing impairment: implications for rehabilitation in developing countries
  248. Polio-vaccination boycott in Nigeria
  249. Corrigendum to “Benefits and challenges of newborn hearing screening for developing countries” [Int. J. Pediatr. Otorhinolaryngol. 68 (2004) 287–305]
  250. Benefits and challenges of newborn hearing screening for developing countries
  251. Hearing impairment in children with impacted cerumen
  252. Early Detection of Hearing Impairment in a Developing Country: What Options?: Identificación temprana de problemas auditivos en países en desarrollo: ¿Qué opciones hay?
  253. Hearing impairment prevention in developing countries: making things happen
  254. The hearing profile of Nigerian school children
  255. West African children in private foster care in City and Hackney